Navigation Links
Amicus Therapeutics Announces Third Quarter 2008 Financial Results
Date:11/3/2008

effort, Amicus continues to conduct preclinical studies in Parkinson's disease and is investing in new research aimed at evaluating disease targets for other neurodegenerative and genetic disorders. In September 2008, the Company entered into a lease for laboratory space for a small scale research facility in San Diego, Calif. This facility will complement Amicus' core research and development activities in New Jersey, while allowing closer access to the significant scientific and biotechnology resources in the San Diego community.

Shire Collaboration:

In November 2007, Amicus entered into a strategic collaboration with Shire Human Genetic Therapies, Inc., a wholly-owned subsidiary of Shire plc, to jointly develop Amicus' three lead pharmacological chaperone compounds for lysosomal storage disorders, Amigal, Plicera and AT2220. In this collaboration, valued at up to $440 million including an up front payment and success based clinical and sales milestones and excluding royalties and cost sharing, Shire reimburses world-wide development costs on a 50/50 basis, and in return Shire received rights to commercialize these products outside of the U.S. while Amicus retains all rights to commercialize these products in the U.S. In addition, Amicus leads development operations through the end of Phase 2 clinical trials. The companies then share responsibility for Phase 3 clinical trial development leveraging Shire's significant ex-U.S. regulatory and clinical experience as well as its commercial infrastructure.

Additional Financial Results & Notes

On a reported basis, the net loss attributable to common stockholders for the three months ended September 30, 2008, was $8.2 million as compared to $10.3 million for the same period in 2007. On a non-GAAP basis, the net loss for the three months ended September 30, 2008, was $6.6 million as compared to $9.2 million in the same period in 2007.

Amicus recorded revenue during the third quarter of 20
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Amicus Therapeutics Announces Third Quarter 2008 Results Release Date
2. Amicus Therapeutics to Present at the 2008 UBS Global Life Sciences Conference
3. Amicus Therapeutics Opens Research Facility in San Diego
4. Amicus Therapeutics to Present at the 2008 BioCentury NewsMakers in the Biotech Industry Conference
5. Amicus Therapeutics Announces Second Quarter 2008 Results Release Date
6. Amicus Therapeutics Announces First Quarter 2008 Financial Results
7. Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference
8. Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease
9. Amicus Therapeutics to Present at the BIO CEO & Investor Conference 2008
10. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
11. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... -- Vermillion, Inc. (NASDAQ: VRML ), a bio-analytical solutions ... Herbert Fritsche , Ph.D., the Lab Director of Vermillion,s ... the 2015 Abbott Award, given by the International Society ... the field of basic or clinical oncology. Dr. Fritsche ... in Zakopane, Poland . Prior to ...
(Date:9/3/2015)... -- According to a new market research ... Flash), GC, Other Components (Autosamplers, Detectors, Fraction Collectors), by ... & Global Forecasts to 2020", published by MarketsandMarkets, The ... Billion by 2020 from USD 7.062 Billion in 2015, ... tables and 36 figures spread through 277 Pages and ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... If you ... in Boston this October, you will also want to sign up for the ... October 18th. The tour includes a walk through of the (8) chemistry teaching ...
(Date:9/2/2015)... Mich. and LIBERTYVILLE, Ill. (PRWEB) , ... ... ... NSF International, a leading provider of regulatory compliance, quality systems, analytical testing, ... LLC, a consulting firm with expertise in medical device products/processes development, design ...
Breaking Biology Technology:Vermillion Announces Dr. Herbert Fritsche as Recipient of the 2015 Abbott Award from the International Society of Oncology and Biomarkers 2Chromatography Instruments Market Worth $ 9.223 Billion by 2020 2Chromatography Instruments Market Worth $ 9.223 Billion by 2020 3Chromatography Instruments Market Worth $ 9.223 Billion by 2020 4Erlab Invites You to Tour the Largest Installation of Filtered Fume Hoods in the World 2NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 2NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 3NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 4NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 5NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 6NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 7
... Verenium Corporation,(Nasdaq: VRNM ), a leading ... the development of high-performance specialty enzymes, announced,today that ... present at,the upcoming Canaccord Adams 28th Annual Global ... 10:30 a.m. ET on Thursday, August 14,and will ...
... SOUTH SAN FRANCISCO, Calif., Aug. 7 Monogram,Biosciences, Inc. ... Young, CEO,and Chairman, is scheduled to present an update ... Conference on Wednesday, September,3, 2008 at 11:30 a.m. (Eastern ... To access the live audio broadcast or the subsequent ...
... Medicsight PLC, a subsidiary,of MGT Capital Investments, Inc. ... in the,development of Computer-Aided Detection (CAD) and image ... from the Brazilian regulatory,agency, Agencia Nacional de Vigilancia ... Chief Executive of Medicsight, commented: "This is,another important ...
Cached Biology Technology:Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference 2Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference 3Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008 2Medicsight Receives Brazilian State Food and Drug Administration Approval for ColonCAD Software 2Medicsight Receives Brazilian State Food and Drug Administration Approval for ColonCAD Software 3
(Date:8/4/2015)... 2015 Research ... the addition of the "Digital Forensics ... Sub-Segment (Computer Forensics, Network Forensics, Mobile Device ... Vertical and Region - Global Forecast to ... By Component (Hardware, Software, and Service), ...
(Date:8/3/2015)... 2015 Synaptics, Inc. (Nasdaq: SYNA ), ... that members of the executive management team will present ... Technology Leadership Forum on Tuesday, August 11, 2015 at ... at the Sonnenalp Resort in Vail, CO. ... forward-looking information. An audio webcast of the event will ...
(Date:7/31/2015)... de julio de 2015 BGI llevará a cabo ... del 22 al 25 de octubre de 2015, en ... conferencia celebra su décimo aniversario este año. Desde su ... de las reuniones anuales más influyentes del mundo en ... las conferencias científicas más dinámicas, entusiastas y amenas. ...
Breaking Biology News(10 mins):Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3
... 2013 Elsevier, a world-leading provider of scientific, ... announced that it received six 2012 PROSE Awards ... PROSE Awards the American Publishers Awards for ... the Association of American Publishers, Professional and Scholarly ...
... With biomedical scientists struggling to collect and analyze millions ... human health, the National Institutes of Health has launched ... framework and start training future scientists to tap that ... story in the current edition of Chemical & ...
... are needed to remove pollutants from water. RUB researchers ... seven different countries in order to develop a photocatalyst ... purpose, they combine sunlight-absorbing semiconductors and nanostructured materials which ... to implement the newly developed photocatalysts into a liquid ...
Cached Biology News:Elsevier wins 6 PROSE Awards 2Painting with catalysts: Nano-engineered materials for detoxifying water by use of sunlight 2
... rapid analytical to medium scale affinity purification ... vectors. Sufficient reagents are provided for purification ... under native or denaturing conditions. Crude samples ... retains STag fusion proteins. After unbound proteins ...
... AAIPharmas Biotech Solutions Group combines deep experience, ... special qualities of collaborative team chemistry. This ... concept to approval and beyond.,With AAIBiotech, you ... But you get more than that: its ...
S-100 alpha/beta chain (8B10)...
... number is a new product number, ... number. If showing no availability yet, ... number (Z71,487-9) or contact customer service ... neck 100 mm, No. of sidearm ...
Biology Products: